Pharmacodynamic monitoring of cyclosporin a reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older

Therapeutic Drug Monitoring

Volumn 33, Issue 6, 2011, Pages 694-698

  Sommerer, Claudia ^a   Schnitzler, Paul ^b   Meuer, Stefan ^b   Zeier, Martin ^a   Giese, Thomas ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cyclosporin A; Monitoring; NFAT; Pharmacodynamics; Renal transplantation; Senior patients

Indexed keywords

BETA ACTIN; CYCLOPHILIN B; CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; METHYLPREDNISOLONE; TRANSCRIPTION FACTOR NFAT;

AGE DISTRIBUTION; AGED; AGING; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG MONITORING; FEMALE; GENE EXPRESSION REGULATION; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MALE; NEOPLASM; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS PNEUMONIA;

AGED; CALCINEURIN; COHORT STUDIES; CYCLOSPORINE; CYTOKINES; DRUG MONITORING; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; GERMANY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; NEOPLASMS; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 84856115743     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318237e33c     Document Type: Article

References (25)

1. Mendonca HM, Dos Reis MA, de Castro de Cintra Sesso R, et al. de Castro de Cintra Sesso R, et al. Renal transplantation outcomes: a comparative analysis between elderly and younger recipients. Clin Transplant. 2007;21:755-760. (Pubitemid 350056144)
2. Meier-Kriesche HU, Ojo A, Hanson J, et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation. 2000;69:885-889. (Pubitemid 30174116)
3. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation. 2007;84:285-291. (Pubitemid 47258313)
4. Meier-Kriesche HU, Kaplan B. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive? Drugs Aging. 2001;18:751-759. (Pubitemid 33135197)
5. de Fijter JW. The impact of age on rejection in kidney transplantation. Drugs Aging. 2005;22:433-449. (Pubitemid 41003072)
6. Morales JM, Campistol JM, Andres A, et al. Immunosuppression in older renal transplant patients. Drugs Aging. 2000;16:279-287. (Pubitemid 30209599)
7. Giese T, Sommerer C, Zeier M, et al. Approaches towards individualized immune intervention. Dig Dis. 2010;28:45-50.
8. Sommerer C, Giese T, Meuer S, et al. Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit? Nephrol Dial Transplant. 2009;24:21-27.
9. Giese T, Zeier M, Meuer S. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors. Nephrol Dial Transplant. 2004;19(suppl 4): iv55-iv60. (Pubitemid 39136707)
10. Giese T, Zeier M, Schemmer P, et al. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation. 2004;77:339-344. (Pubitemid 38209728)
11. Sommerer C, Konstandin M, Dengler T, et al. Pharmacodynamic monitoring of cyclosporine A in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation. 2006;82:1280-1285. (Pubitemid 44832909)
12. Sommerer C, Giese T, Schmidt J, et al. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Transplantation. 2008;85:15-21.
13. Konstandin MH, Sommerer C, Doesch A, et al. Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients. Transpl Int. 2007;20:1036-1043. (Pubitemid 350043847)
14. Zahn A, Schott N, Hinz U, et al. Immunomonitoring of nuclear factor of activated T cells-regulated gene expression: the first clinical trial in liver allograft recipients. Liver Transpl. 2011;17:466-473.
15. Billing H, Giese T, Sommerer C, et al. Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients. Pediatr Transplant. 2010;14:844-851.
16. Bernardo JF, McCauley J. Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions. Drugs Aging. 2004;21:323-348. (Pubitemid 38530458)
17. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89:779-795.
18. Levey AS, Greene T, Schluchter MD, et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol. 1993;4:1159-1171.
19. Pawelec G, Ouyang Q, Colonna-Romano G, et al. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol. 2002;23:330-332. (Pubitemid 34717900)
20. Ginaldi L, De Martinis M, Monti D, et al. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol. 2005;26:79-84.
21. Pawelec G, Koch S, Griesemann H, et al. Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother. 2006;55:981-986. (Pubitemid 43673589)
22. Shah T, Bunnapradist S, Hutchinson I, et al. The evolving notion of "senior" kidney transplant recipients. Clin Transplant. 2008;22:794-802.
23. Bradley BA. Does the risk of acute rejection really decrease with increasing recipient age? Transpl Int. 2000;13(suppl 1): S42-S44.
24. Liu S, Lutz J, Antus B, et al. Recipient age and weight affect chronic renal allograft rejection in rats. J Am Soc Nephrol. 2001;12:1742-1749. (Pubitemid 32674438)
25. Lufft V, Kliem V, Tusch G, et al. Renal transplantation in older adults: is graft survival affected by age? A case control study. Transplantation. 2000;69:790-794. (Pubitemid 30174098)